European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires IAEA Consultants Meeting on.

Slides:



Advertisements
Similar presentations
1ISO policy on global relevance MAS/PGR Jannuary 2006 ISO Policy on global relevance.
Advertisements

Office International des Épizooties World Organisation for Animal Health created in 1924 in Paris.
Transnationality and Interregionality or how to connect projects and other ESF actors all over Europe Mr Johannes Wikman.
European Economic and Social Committee Consultative Committee on Industrial Change "CCMI" P r e s e n t a t i o n of J á n o s T Ó T H Member of the EESC.
1 The new ESF Investing in your Future -
Application of the OIE-PVS Tool to Aquatic Animal Health Services Keren Bar-Yaacov CVO Norway, member of OIE-PVS ad-hoc working group OIE conference Aquatic.
PROPOSAL FOR SETTING-UP THE IBERIAN GAS MARKET (MIBGAS) Harmonization of trading licenses in the Iberian area Terms of reference 10 July 2008.
Health and Consumers Health and Consumers The EU coordination mechanism Moritz Klemm, Animal Health Unit, Directorate for Veterinary and International.
OIE International Standards The OIE Standard Setting Process Regional Information Seminar for Recently Appointed OIE Delegates Brussels, Belgium, 18 –
0 1 Mirrorgroup Animal Health Dutch experiences 2 Trigger, initiative and chair Initiative: CVO European trigger: request Executive Board of ETPGAH to.
Convergence towards the "Small Business Act" EUROMED Invest Academy Belgrade, March 2015 Christos Kyriatzis, Deputy Head of Unit, International.
Global Trends in the Chemical Industry 53 rd. Council of the Russian Chemists Union Board of Directors of Association Tsentrlak Yaroslavl, 23 November.
Presentation 4.2 CODEX STANDARDS ON SAFETY Section IV Food Quality and Standards Service (ESNS) Food and Nutrition Division. FAO.
European Manufacturers of Veterinary Diagnostics EMVD Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV Presentation on the activities.
Overview of Medical Devices Sector Saudi Food and Drug Authority (Saudi Arabia) Dr. Saleh Al Tayyar Director General Medical Devices Sector Saudi Food.
GLOBAL REGULATORY STRATEGY CONSIDERATIONS SCIENTIFIC SARAH POWELL EXECUTIVE DIRECTOR, REGULATORY STRATEGIES SEPTEMBER 14-17, 2008 BOSTON, MA.
Improving the performance of veterinary statutory bodies – experience with an OIE Veterinary Legislation Agreement Nicholas Kauta, OIE Delegate for Uganda,
Capacity building activities of the OIE STDF WORKSHOP on Capacity Building Tools Geneva, 31 March 2008 Dr Sarah Kahn Director, International Trade Department.
Harmonisation, Standardisation and approval of diagnostic kits Manufacturers point of view on validation of veterinary diagnostics – Seeking an efficient.
Public –Private Partnership as a means to Improve Animal Welfare Globally Dr Ann Wilkinson, President, SSAFE Food SafetyAnimal HealthPlant Health Food.
Aid for Trade Needs Assessment Ukraine: Trade and Human Development Igor Burakovsky, Institute for Economic Research and Policy Consulting (Ukraine) 14.
1 OIE CAPACITY BUILDING ACTIVITIES Regional Information Seminar for Recently Appointed OIE Delegates 18 – 20 February 2014, Brussels, Belgium Dr Mara Gonzalez.
A New Start for EUTO Redruth, 29 September 2012 Henk Schüller.
1 OIE Response to the HPAI Threat in the SADC Region 1 st SADC Meeting on Avian Influenza Pretoria, South Africa 7-9 March 2006 Sub Regional Representation.
The new EU cohesion policy ( ) EASPD Project Development Workshop May 10th – Sofia (BG) Jelle Reynaert – Policy Officer.
1 OIE Global Conference on Veterinary Education and the role of Veterinary Statutory Body 4 – 6 December 2013 Foz do Iguazu (Brazil)
OVERVIEW OF THE ROLES OF VARIOUS INSTITUTIONS AND REGULATORY FRAMEWORK FOR AFLATOXIN CONTROL IN TANZANIA RAYMOND N. WIGENGE DIRECTOR OF FOOD SAFETY TFDA.
Public and private sector roles in addressing animal health issues Strengthening the relationship between public and private sector roles (commercial and.
“The Quality Infrastructure in Lebanon” Export Norms, Quality Control and Competitiveness FUTURE PROGRAMME Prepared By Ali Berro Director of Quality Programme.
ISPE Central Canada Chapter Annual Meeting September 28, 2006 Yvon R. Tessier Pharmaceutical contract manufacturing challenges.
16-17 November 2005 COSCAP – NA Project Steering Group Guangzhou, China 1 Co-operating with the European Aviation safety Agency.
DISCONTOOLS “Disease Control Tools” Telmo Valinhas Project Manager CNA – Mirror Groups Meeting, February 27th, 2008.
The industrial relations in the Commerce sector EU Social dialogue: education, training and skill needs Ilaria Savoini Riga, 9 May 2012.
THE EXPERIENCE OF ESTABLISHING THE VETERINARY STATUTORY BODY IN KYRGYZSTAN Zh. Dadybaev, K. Mamatkulov, R. Tashbaeva.
Strengthening “Water & Health” in the EECCA countries A project in development.
Steinlova Kvetoslava - MARS Rapporteur. UNECE International Seminar on Product Safety and Counterfeiting (2007) Second UNECE Forum on Market Surveillance.
Lecture held on the Food Safety Conference March 2004 Dublin 1 Control Methods and Organisation of Official Controls in Hungary Dr. Peter A. BIACS,
Project funded by the Spanish Ministry of Science and Innovation and the European Regional Development Fund PROGRESS REPORT SEPTEMBER 2009 Brussels, 22.
Future needs for capacity building and recommendations to the OIE Dr Sarah Kahn Consultant to the OIE
Electricity Regional Initiative Central Eastern European Region Convergence & Coherence Sven Kaiser E-Control CEE Stakeholder Group Meeting 7 th November.
Ministerial Declaration and Concluding Remarks MD PhD Karin Tegmark Wisell Chair AMR expert group, NDPHS.
VICH Training Strategy Steven D. Vaughn, DVM Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine U.S. Food and Drug Administration.
BIMILACI 2007 Partners for Quality Infrastructure: The FIDIC Vision Washington, May 10, 2007 Dr. Jorge Díaz Padilla FIDIC President.
Industry: trends, concerns hopes and ideas VICH5 Conference Carel du Marchie Sarvaas, Executive Director October 2015.
-What is VICH, History and Objectives Hervé MARION, DVM VICH Secretariat.
1 VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER 2015, TOKYO VICH AND VETERINARY MEDICINES AVAILABILITY VICH5 CONFERENCE, OCTOBER.
Workshop on “EU Enlargement: Regulatory Convergence in Non-acceding Countries” Athens 7 – 8 November 2003 Regulatory Convergence and Technical Standards.
Link between legal framework of VMP regulation and VICH GLs in Japan Takashi Kozasa DVM Ministry of Agriculture, Forestry and Fisheries Government of Japan.
Medium Term Budget Policy Statement Presentation to: Joint Budget Committee 17 November 2003.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 31 – Common Foreign and Security Policy.
BioEnergy Sustaining The Future 2 BESTF2 Briefing Event 11 th December 2013 Dr Megan Cooper, BESTF co-ordinator.
A European Academic Network for Vaccine Research An Idea from the Danish Mirror Group under ETPGAH Working group: Jens Kjær – Boehringer Ingelheim DK Poul.
1 THE OIE REPORT 32 nd VICH SC Meeting / 6 th VICH Outreach Forum Meeting Jean-Pierre Orand, Anses, France, OIE Collaborating Centre.
Waiving TABST for vaccines Argentina: Not an allowed procedure today Require batch safety tests in laboratory animals, repeated by authorities Currently.
An example of a partnership is the Commonwealth Health Professions Alliance of which the CNF is a founding member. The CHPA is an alliance of Commonwealth.
Importance of statistics data for regional cooperation
Nordic Cooperation on Ethical Review Procedures Nordforsk – nordic trial alliance MIKA SCHEININ
International Organization
Seminar for National Delegates to the OIE: “Development of public–private partnerships to support Veterinary Services” 10 November 2015, Kaslik.
Declaration of the 11th ministerial-level PAC meeting in Berlin 2015 From strategies to action – how to tackle the challenges of Antimicrobial Resistance.
The Sixth Strategic Plan: Camels Concerned
EU Reference Centres for Animal Welfare
OIE Reference Laboratories transboundary animal disease control
Evaluation of veterinary services outcomes IN MIDDLE EAST
An important tool in the prevention of animal diseases
PVS Gap Analysis outcomes in Middle EAST
OIE’s fourth Strategic Plan
OIE’s standard setting process
Experience of the implementation of FP6; preparations towards FP7
PVS Gap Analysis outcomes in Middle EAST
Presentation transcript:

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires IAEA Consultants Meeting on Standards, referencing and validation November 21-24, 2006 Vienna, Austria

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV  History  Members  Priorities: Harmonization of Regulations & OIE procedure & Recommendations Reference panels European affairs: ETPGAH participation Unfair competition of Public Laboratories  Conclusion

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV History  The Association was initially created in 2000 with the goal to defend the interests of diagnostics producers, by working on two major subjects: the harmonization of the complicated European Regulatory situation for veterinary diagnostics the false competitive position of some public laboratories (producers of diagnostics and controlling at the same time our commercial activity).  The adoption of the OIE procedure May 2005, experienced as an addition to existing rules and fees, was an impulse to resuscitate the association

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires AEFRV Members  Note: The majority of our members are small enterprises  BioX  CEDI Diagnostics  Guildhay  IDEXX  INGENASA  MegaCor  Institut Pourquier  SIMV  Svanova  SYNBIOTICS

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires  Active Regulation is present in many countries of the world, most often using vaccine regulations as a template. The regulation is therefore stringent. Example: USA; Japan; China  In Europe, some countries like Germany, Spain, Portugal and some others actively regulate veterinary diagnostic tests  As a result there are different coexisting regulations, that are costly in time and fees. Harmonization of existent regulations on Veterinary Diagnostics (1)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires  Batch control: Some countries have batch control for each batch of product that is commercialized. Batch controls are not recognized between European member states.  As a result the same batch is tested by different reference laboratories, thereby multiplying marketing costs. Harmonization of existent regulations on Veterinary Diagnostics (2)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires In May 2005, the OIE registration Procedure was launched:  This registration procedure comes in complement to the existing ones and is very costly (9000 € every 5 years, plus 0.1% of the annual sales as additional tax).  Moreover: The procedure itself is long and requiring quite some investment in time and money for “fitness for purpose studies” as asked in the procedure. Harmonization of existent regulations on Veterinary Diagnostics (3)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires ACTION:  The AEFRV and the OIE are actually working on the convergence of interests to make the procedure evolve into something workable for the OIE and our members Harmonization of existent regulations on Veterinary Diagnostics (4)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires Recommendations Harmonization & OIE procedure  The AEFRV recommends the procedure to be more accessible, less expensive, without any annual tax  The AEFRV recommends to have the procedure recognized and accepted as an alternative procedure by countries having an active regulation on veterinary diagnostics  The AEFRV will support joint OIE / EU initiatives to streamline existent regulations and regulation projects into a more workable regulatory situation

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires  AEFRV members think that manufacturers of veterinary diagnostics should be actively involved in the constitution of these sera panels in cooperation with organizations such as the OIE reference laboratories.  Requirements for reference sera / panels: Quantities should be large Sera should be accessible to manufacturers, public laboratories, OIE laboratories Many other items: Refer our current discussions The constitution of reference sera or panels

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires European Affairs: - ETPGAH (1) The aim of the Technology Platform is:  To facilitate and accelerate the development and distribution of the most effective tools for controlling animal diseases of major importance to Europe and the rest of the world, thereby improving human and animal health, food safety and quality, animal welfare, market access, contributing to achieving the Millennium Development Goals

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires  To attain this goal, the technology platform formulated a number of strategic objectives that concentrate on animal health, welfare and well-being, the control of zoonotic diseases, maintenance of competitive industry, facilitating the transfer of discoveries by providing a constructive regulatory environment, develop global alliances with international organizations, improve education, alleviate poverty in developing countries, create private-public partnerships.  A vision paper underlining this goal was published and a strategic research agenda was elaborated, which formulates a number of recommendations (>60). European Affairs: - ETPGAH (2)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires Contributions of the AEFRV since last March:  Elaboration of Chapter 6.4 in the Strategic Research agenda (SRA) with a number of recommendations  These recommendations are addressed by 4 coordination groups in which the AEFRV is present  The AEFRV is represented in the board of the ETPGAH since last Summer European Affairs: - ETPGAH (3)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires  The implementation of the SRA should result in a correct prioritization of animal diseases, enabling the research directorate to allocate research budgets to priority projects.  Why should diagnostic producers be present?  The tool for the control of animal disease is often the diagnostic product alone: In many cases vaccination is not allowed.  Diagnostics producers have the know-how to discuss the role of diagnostics with experts from public research institutions and the vaccine industry. European Affairs: - ETPGAH (4)

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires Competition of Public Laboratories  Diagnostics producers undergo harsh competition from public laboratories whose primary goal is to provide surveillance to animal health, by acting as an independent reference laboratory for national governments. Some of them are also OIE reference laboratories.  Their expertise is highly appreciated and some perform research on a high level  However, some public laboratories produce diagnostic reagents, and commercialize them.

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires Competition of Public Laboratories  In Europe, some public laboratories block the market, as their method or test is the only one authorized (even if better tests or methods exist)  We feel that a diagnostics producing laboratory cannot objectively evaluate commercial tests  Public laboratories do not always adhere to a quality system (Most diagnostic producers are ISO certified)  The AEFRV discloses this conflict of interest

European Association of Veterinary Diagnostics manufacturers Association Européenne des Fabricants de Réactifs Vétérinaires Conclusion  The AEFRV will continue to work on these items!